Combination antibiotics for Chlamydia-induced arthritis: Breakthrough to a cure?

Arthritis and Rheumatism

Volumn 62, Issue 5, 2010, Pages 1203-1207

  Rihl, Markus ^a   Kuipers, Jens G ^b   Köhler, Lars ^c   Zeidler, Henning ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Medizinische Klinik   (Germany)

^c Rheumatologische Facharztpraxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; DOXYCYCLINE; PLACEBO; RIFAMPICIN;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE CLASSIFICATION; EDITORIAL; GASTROINTESTINAL SYMPTOM; HUMAN; NOMENCLATURE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REACTIVE ARTHRITIS;

ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; DRUG THERAPY, COMBINATION; HUMANS;

EID: 77951719536     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27401     Document Type: Editorial

References (22)

1. Toivanen A, Toivanen P. Reactive arthritis. Best Pract Res Clin Rheumatol 2004;18:689-703.
2. Kvien TK, Gaston JS, Bardin T, Butrimiene I, Dijkmans BA, Leirisalo-Repo M, et al. Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis 2004;63:1113-1119
3. Soderlin MK, Kautiainen H, Jonsson D, Skogh T, Leirisalo-Repo M. The costs of early inflammatory joint disease: a population-based study in southern Sweden. Scand J Rheumatol 2003;32: 216-224
4. Kuipers JG, Scharmann K, Wollenhaupt J, Nettelnbreker E, Hopf S, Zeidler H. Sensitivities of PCR, MicroTrak, ChlamydiaEIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid. J Clin Microbiol 1995;33:3186-3190
5. Schnarr S, Putschky N, Jendro MC, Zeidler H, Hammer M, Kuipers JG, et al. Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: results of a prospective study. Arthritis Rheum 2001;44:2679-2685
6. Carter JD, Gerard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, et al. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 2009;60: 1311-1316
7. Zeidler H, Rihl M. Time to prove the infective etiology of ankylosing spondylitis and related spondyloarthritides: comment on the article by Carter et al [letter]. Arthritis Rheum 2009;60: 3519-3520
8. Kuipers JG, Zeidler H, Kohler L. How does Chlamydia cause arthritis? Rheum Dis Clin North Am 2003;29:613-629
9. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am 2009;35:21-44.
10. Putschky N, Pott HG, Kuipers JG, Zeidler H, Hammer M, Wollenhaupt J. Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial. Ann Rheum Dis 2006;65:1521-1524
11. Sieper J, Fendler C, Laitko S, Sorensen H, Gripenberg-Lerche C, Hiepe F, et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum 1999;42:1386-1396
12. Wakefield D, McCluskey P, Verma M, Aziz K, Gatus B, Carr G. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum 1999;42: 1894-1897
13. Dreses-Werringloer U, Padubrin I, Jurgens-Saathoff B, Hudson AP, Zeidler H, Kohler L. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother 2000;44:3288-3297
14. Dreses-Werringloer U, Padubrin I, Zeidler H, Kohler L. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 2001;45:3001-3008
15. Engel JN, Pollack J, Perara E, Ganem D. Heat shock response of murine Chlamydia trachomatis. J Bacteriol 1990;172:6959-6972
16. Carter JD, Valeriano J, Vasey FB. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis: a prospective, randomized 9-month comparison. J Rheumatol 2004;31:1973-1980
17. Carter JD, Espinoza LR, Inman RD, Sneed KB, Ricca LR, Vasey FB, et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum 2010;62:1298-1307.
18. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al, and the European Spondylarthropathy Study Group. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-1227
19. Zochling J, Brandt J, Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (Oxford) 2005;44:1483-1491
20. Inman RD, Whittum-Hudson JA, Schumacher HR, Hudson AP. Chlamydia and associated arthritis. Curr Opin Rheumatol 2000; 12:254-262
21. Zeidler H, Kuipers J, Kohler L. Chlamydia-induced arthritis. Curr Opin Rheumatol 2004;16:380-392
22. Blasi F, Tarsia P, Aliberti S. Chlamydophila pneumoniae. Clin Microbiol Infect 2009;15:29-35.